Stay in the know
Discover the latest financial news and exclusive features from Laidlaw
A BRIGHTER FUTURE, with Laidlaw episode #6: Laidlaw Five with David Garrity (Session 4)
Podcast Series: A BRIGHTER FUTURE. Listen to our third session of the Laidlaw Five, our ongoing podcast series.
A BRIGHTER FUTURE, with Laidlaw. Episode #5 Laidlaw Five with David Garrity Session 3 episode of A Brighter Future
Podcast Series: A BRIGHTER FUTURE. Listen to our third session of the Laidlaw Five, our ongoing podcast series.
David Garrity: New ’Stay-At-Home’ Paradigm Favors Big Tech
In the spirit of the Chinese curse, “may you live in interesting times,” we are certainly in the thick of it at the moment as efforts to contain the COVID-19 coronavirus to China have failed. There are now 140 countries that have reported infections and the weekend has seen the announcement of radical steps such as major U.S. cities (e.g. Chicago, IL; Los Angeles, CA; New York, NY) taking steps to sharply curtail public activities as the U.S. Centers for Disease Control & Prevention (CDC) has issued guidance that events involving 50 people or more not be held for the next two months...
Laidlaw & Company enhances their Wealth Management offering with Envestnet | MoneyGuide
Laidlaw & Company enhances their Wealth Management offering with Envestnet | MoneyGuide NEW YORK, NY, UNITED STATES, March 11, 2020 /EINPresswire.com/ -- Laidlaw Wealth Management is pleased to announce it has chosen Envestnet, a [...]
How artificial intelligence can control disease outbreaks
Watch Ann Marie Sastry's interview on CNBC's “Squawk Alley”. The CEO of AMESITE talks about her company and how artificial intelligence can be used in disease outbreaks and even to track the coronavirus. WATCH [...]
Laidlaw served as Co-Manager on the $21.75mm EyePoint Pharmaceuticals (EYPT) Follow-On Offering.
Laidlaw Capital Markets is pleased to announce today's pricing of a $21,750,000 Follow-On Offering for EyePoint Pharmaceuticals (EYPT). Laidlaw proudly served as Co-Manager alongside Guggenheim, who was Sole Book-Runner on the transaction. See full Press [...]
Laidlaw served as Sole Book-Runner on the $10mm BioSig Technologies (BSGM) Follow-On Offering.
Laidlaw Capital Markets is pleased to announce today's pricing of a $10,000,000 Follow-On Offering for BioSig Technologies (BSGM). Laidlaw proudly served as the Sole Book Runner on the transaction. See full Press Release on BioSig Website [...]
Defiance ETFs LLC Rings The Closing Bell®
Laidlaw was proud to attend the closing bell ceremony at the NYSE yesterday. Defiance ETFs LLC is the first 5G ETF (NYSE Arca: FIVG) Alex Shtaynberger, Richard Calhoun and Keith Hassan from Laidlaw attended and were [...]
COVID-19 Letter